Themis Medicare Ltd (THEMISMED) Share Price Target 2026, 2027 upto 2030

Themis Medicare Ltd. (THEMISMED) belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry. The stock closed at Rs. 116.72 on 09 July 2026. In this updated report, we will explore THEMISMED share price target for 2026, 2027, 2028, 2029 and 2030 using monthly target data, year-end target ranges, and current technical trends.

For long-term THEMISMED share price forecast up to 2030, we use multiple ML-based models instead of a single fixed projection. The forecast combines LightGBM quantile regression and ExtraTrees quantile forest to produce bear, base and bull ranges. THEMISMED's recent data shows a 10.19% one-month move, a 40.88% three-month move, and a -21.14% drawdown from its 12-month high area. Because recent volatility is high and model confidence is medium, these targets are best read as a forecast range rather than a single fixed price.

THEMISMED Share Price Target 2026 to 2030: Quick View

Based on the latest forecast model, THEMISMED's 2030 consensus base target is Rs. 215.15. The bear case stands near Rs. 109.53, while the bull case extends up to Rs. 356.34. For 2026, the year-end consensus base target is Rs. 123.00, with a forecast range of Rs. 100.24 to Rs. 155.82.

THEMISMED Current Performance and 52-Week Position

THEMISMED Price Recovery Tracker

Recent Closing Prices of THEMISMED

THEMISMED Share Price Target 2026

THEMISMED share price target for 2026 is shown below with bear, base and bull scenarios for each month.

Summary of THEMISMED Share Price Forecast for 2026

• The initial price target for Themis Medicare Ltd. in 2026 is projected near Rs. 102.68, with the forecast range starting from the first available model month. This starts below the latest close, keeping the early setup cautious.
• The mid-year price target for Themis Medicare Ltd. could reach Rs. 116.06 in the base case. The first-half move is stronger than the full-year average path, so this year is front-loaded in the forecast.
• By the end of 2026, the price target for Themis Medicare Ltd. is projected near Rs. 123.00 in the base case, while the bear-to-bull range stands between Rs. 100.24 and Rs. 155.82. This points to a moderate upward base case rather than an aggressive one-way forecast.

THEMISMED Share Price Target 2027

THEMISMED share price target for 2027 is shown below with bear, base and bull scenarios for each month.

Summary of THEMISMED Share Price Forecast for 2027

• The initial price target for Themis Medicare Ltd. in 2027 is projected near Rs. 133.57, with the forecast range starting from the first available model month. This opens above the previous year-end base target, showing continuation in the consensus path.
• The mid-year price target for Themis Medicare Ltd. could reach Rs. 156.00 in the base case. The first-half move is stronger than the full-year average path, so this year is front-loaded in the forecast.
• By the end of 2027, the price target for Themis Medicare Ltd. is projected near Rs. 130.95 in the base case, while the bear-to-bull range stands between Rs. 104.26 and Rs. 154.93. This keeps the year mostly range-bound in the base case, even though the bull scenario leaves room for upside.

THEMISMED Share Price Target 2028

THEMISMED share price target for 2028 is shown below with bear, base and bull scenarios for each month.

Summary of THEMISMED Share Price Forecast for 2028

• The initial price target for Themis Medicare Ltd. in 2028 is projected near Rs. 132.77, with the forecast range starting from the first available model month. This opens above the previous year-end base target, showing continuation in the consensus path.
• The mid-year price target for Themis Medicare Ltd. could reach Rs. 142.25 in the base case. The first-half movement is steady, with no sharp jump between the opening and mid-year targets.
• By the end of 2028, the price target for Themis Medicare Ltd. is projected near Rs. 154.52 in the base case, while the bear-to-bull range stands between Rs. 105.85 and Rs. 204.51. This points to a moderate upward base case rather than an aggressive one-way forecast.

THEMISMED Share Price Target 2029

THEMISMED share price target for 2029 is shown below with bear, base and bull scenarios for each month.

Summary of THEMISMED Share Price Forecast for 2029

• The initial price target for Themis Medicare Ltd. in 2029 is projected near Rs. 156.67, with the forecast range starting from the first available model month. This opens above the previous year-end base target, showing continuation in the consensus path.
• The mid-year price target for Themis Medicare Ltd. could reach Rs. 167.85 in the base case. The range is wide by mid-year, so the base target should be read with the lower and upper scenarios.
• By the end of 2029, the price target for Themis Medicare Ltd. is projected near Rs. 182.33 in the base case, while the bear-to-bull range stands between Rs. 107.61 and Rs. 269.95. This points to a moderate upward base case rather than an aggressive one-way forecast.

THEMISMED Share Price Target 2030

THEMISMED share price target for 2030 is shown below with bear, base and bull scenarios for each month.

Summary of THEMISMED Share Price Forecast for 2030

• The initial price target for Themis Medicare Ltd. in 2030 is projected near Rs. 184.87, with the forecast range starting from the first available model month. This opens above the previous year-end base target, showing continuation in the consensus path.
• The mid-year price target for Themis Medicare Ltd. could reach Rs. 198.07 in the base case. The range is wide by mid-year, so the base target should be read with the lower and upper scenarios.
• By the end of 2030, the price target for Themis Medicare Ltd. is projected near Rs. 215.15 in the base case, while the bear-to-bull range stands between Rs. 109.53 and Rs. 356.34. For 2030, the full range is more important than the single base number because long-horizon model uncertainty is higher.

THEMISMED Historical Price and Possible Forecast Path

The chart below combines THEMISMED's available monthly closing history with possible bear, base and bull forecast paths up to 2030. Once the latest page data is regenerated, the history section can show up to five years of month-end closes. The shaded area marks the forecast period, so the future section should be read as scenario data, not a confirmed price path.

Model Comparison for THEMISMED Forecast

THEMISMED Bear, Base and Bull Case Explained

How Strong Is the THEMISMED Forecast Agreement?

For 2030, the model gap between LightGBM and ExtraTrees is 0.00%, which is classified as tight agreement. A tight gap means both models are reading the long-term setup similarly, while a wide gap means the final target should be read with more caution.

Key Takeaways from Forecasted Price for THEMISMED from 2026 to 2030

• 2026: The base target moves from Rs. 102.68 to Rs. 123.00, while the year-end range is Rs. 100.24 to Rs. 155.82.
• 2027: The base target moves from Rs. 133.57 to Rs. 130.95, while the year-end range is Rs. 104.26 to Rs. 154.93.
• 2028: The base target moves from Rs. 132.77 to Rs. 154.52, while the year-end range is Rs. 105.85 to Rs. 204.51.
• 2029: The base target moves from Rs. 156.67 to Rs. 182.33, while the year-end range is Rs. 107.61 to Rs. 269.95.
• 2030: The base target moves from Rs. 184.87 to Rs. 215.15, while the year-end range is Rs. 109.53 to Rs. 356.34.

What Is Driving the THEMISMED Share Price Forecast?

• Momentum: THEMISMED has moved 10.19% over 1 month and 40.88% over 3 months, which makes the recent trend state positive recent trend.
• Volatility: The volatility reading is 70.36%, so the forecast range is read with high volatility.
• Price position: The stock is in the middle part of its 12-month range, with a -21.14% drawdown from the recent high.
• Model agreement: The model comparison table shows whether LightGBM and ExtraTrees are close or wide for the long-term base target.

What Can Change the THEMISMED Forecast?

• If THEMISMED moves back above its 200-day average, the long-term setup can improve because the current SMA 200 status is above its 200-day average.
• If the stock fails to recover from the middle part of its 12-month range, the bear case becomes more relevant than the base case.
• If volatility stays high, the forecast range can remain wide even when the base target moves higher.
• If future model batches reduce the 0.00% 2030 model gap, the long-term target range may become easier to interpret.

Risks and Uncertainty in THEMISMED Long-Term Target

The main uncertainty in the THEMISMED share price target comes from the wide 2030 range, high volatility, and tight model agreement. Long-term forecasts can change materially when new price history, trend data or volatility data is added to the model.

FAQs on THEMISMED Share Price Target

What is THEMISMED share price target for 2030?

THEMISMED share price target for 2030 has a consensus base case of Rs. 215.15. The bear case is Rs. 109.53, while the bull case is Rs. 356.34.

What is THEMISMED share price target for 2026?

THEMISMED share price target for 2026 has a year-end base target of Rs. 123.00, with a forecast range of Rs. 100.24 to Rs. 155.82.

Is the THEMISMED forecast based on machine learning?

Yes. The forecast uses LightGBM quantile regression and ExtraTrees quantile forest, then shows a consensus range.

Can THEMISMED reach Rs. 215.15 by 2030?

The 2030 base case shows Rs. 215.15, which is +84.33% from the latest close. This is a possible model scenario, not a guaranteed target.

What is the bear case target for THEMISMED in 2030?

The bear case target for THEMISMED in 2030 is Rs. 109.53, implying -6.16% from the latest close.

What is the bull case target for THEMISMED in 2030?

The bull case target for THEMISMED in 2030 is Rs. 356.34, implying +205.29% from the latest close.

Why does the THEMISMED forecast range matter?

The forecast range matters because the 2030 range is wide and the model agreement is tight. A wider range means the long-term estimate has more uncertainty.

Is this THEMISMED target a buy or sell recommendation?

No. These targets are scenario-based forecasts generated from price and technical data. They should not be treated as a buy, sell or hold recommendation.